Clinical Trial Update: Ultra-low-dose Chest CT for HHT

View source ↗

Summary

A Mayo Clinic-sponsored trial evaluating ultra-low-dose chest CT for hereditary hemorrhagic telangiectasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemorrhagic Telangiectasia

Snippet

Sponsor: Mayo Clinic | Conditions: Hereditary Hemorrhagic Telangiectasia | Status: COMPLETED